niftify.in

niftify.in

Latest Metropolis Healthcare News

Metropolis Healthcare Stock News and Insights: Stay updated with the latest Metropolis Healthcare stock news and industry trends. Access quick information on Metropolis Healthcare stock buybacks,Metropolis Healthcare results, Metropolis Healthcare company analysis, Metropolis Healthcare live prices, Metropolis Healthcare dividends, Metropolis Healthcare bonus share, board meetings, lifetime highs, Metropolis Healthcare targets, lows, and growth stories with AI—all in one place.

Diagnostic companies like Metropolis Healthcare and Dr Lal PathLabs have implemented price hikes to cope with inflationary pressures
Business Standard

Business Standard

Price hikes improve margins for diagnostic labs amid online competition

Diagnostic companies like Metropolis Healthcare and Dr Lal PathLabs have implemented price hikes to cope with inflationary pressures

Mon, Sep 23, 2024

Due to new criteria, 18 stocks, including Abbott India and Metropolis Health, may be removed from the F&O segment, while 79 stocks are potential entrants. Final decisions rest with SEBI, with a review expected in December 2024.
The Economic Times

The Economic Times

New exit, entry criteria for F&O stocks in force. 18 risk exclusion, Zomato, Jio Fin inclusion aspirants

Due to new criteria, 18 stocks, including Abbott India and Metropolis Health, may be removed from the F&O segment, while 79 stocks are potential entrants. Final decisions rest with SEBI, with a review expected in December 2024.

Sat, Aug 31, 2024

Commenting on the results, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare, said that the company has consistently achieved high growth in patient volume
Business Standard

Business Standard

Patient influx, test volumes raise Metropolis Healthcare's profit by 31%

Commenting on the results, Ameera Shah, Executive Chairperson and Whole-time Director, Metropolis Healthcare, said that the company has consistently achieved high growth in patient volume

Sun, Aug 11, 2024

The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.
The Economic Times

The Economic Times

Metropolis Q1 results: Net profit rises 31% to Rs 38 crore

The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.

Sat, Aug 10, 2024

The healthcare service provider said that its revenue grew around 13% year on year (YoY) in the quarter ended 30 June 2024.
Business Standard

Business Standard

Metropolis Healthcare revenue climbs 13% YoY Q1

The healthcare service provider said that its revenue grew around 13% year on year (YoY) in the quarter ended 30 June 2024.

Tue, Jul 9, 2024